Trial · NCT07903974
Multimodal Intervention for Individuals With Posttraumatic Stress Disorder (PTSD) and Hazardous Alcohol Use
NCT07903974, Not applicable, Not yet recruiting, University of Michigan
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Multimodal Intervention for Individuals With Posttraumatic Stress Disorder (PTSD) and Hazardous Alcohol Use. Trials, record NCT07903974. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07903974
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Multimodal Intervention for Individuals With Posttraumatic Stress Disorder (PTSD) and Hazardous Alcohol Use
- NCT number
- NCT07903974
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 12 participants, estimated
- Lead sponsor
- University of Michigan
- Conditions
- Post Traumatic Stress Disorder PTSD, Hazardous Alcohol Use
- Interventions
- Written Exposure Therapy (WET), Clinician Supported PTSD Coach App (CS-PTSD), Phone follow up, Primary Care Treatment Integrating Motivation and Exposure (PC-TIME)
- First posted
- 2026-10-29
- Last updated
- 2026-10-29
Source ClinicalTrials.gov
Registered outcomes6
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Participant rating of acceptability of intervention | Session 10, Approximately week 15 | Measured using a 7 item Intervention Acceptability scale. The scale ranges from 0- 28. Higher scores indicate greater acceptability. |
| Primary | Percent of participants who engage and complete follow-up timepoints | Session 10, Approximately week 15 | For the purposes of this study complete is defined as 80% |
| Primary | Percent of participants who are eligible agree to participate | Session 10, Approximately week 15 | |
| Primary | Percent of participants who complete daily symptom monitoring | Session 10, Approximately week 15 | For the purposes of this study complete is defined as 80% |
| Secondary | Change in PTSD symptom severity (as measured by the PTSD Symptom Checklist for DSM-5) | Baseline, Session 5, Session 10 (Approximately week 1, 8, 15) | The study team is planning on measuring change at each timepoint. Baseline to visit 5, baseline to visit 10, and visit 5 to visit 10. The checklist is 20 items and each item has a scale of 0 to 4 (total range of 0-80). Higher scores indicate greater symptom severity. |
| Secondary | Change in alcohol use (as measured by the Timeline Follow Back) | Baseline, Session 5, Session 10 (Approximately week 1, 8, 15) | The study team is planning on measuring change at each timepoint. Baseline to visit 5, baseline to visit 10, and visit 5 to visit 10. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants1
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years |
|---|---|---|---|---|---|
| K23MH141149 | Developing a Multimodal Intervention for Individuals with PTSD and Hazardous Alcohol Use in Federally Qualified Health Centers | Grau, Peter | UNIVERSITY OF MICHIGAN AT ANN ARBOR | NATIONAL INSTITUTE OF MENTAL HEALTH | 2026 |
Source NIH RePORTER
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07903974
GET https://conductscience.org/api/trials/v1/NCT07903974/registered